Deferasirox - a rarer cause of Fanconi syndrome

• Autori principali: Iman Khan (Autore), Mustafa Muhammad (Autore), Janki Patel (Autore)
• Natura: Libro
• Pubblicazione: Greater Baltimore Medical Center, 2019-07-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

Deferasirox is a recently approved iron chelator and is widely used to treat iron overload in transfusion-dependent patients. Its once-daily dosing and oral route of administration have made it an appealing alternative to deferoxamine. Recent case studies have brought to light its potential to cause...